Emmaus Medical

Emmaus Medical is a pharmaceutical company dedicated to developing new treatments for rare diseases and conditions.

Emmaus Medical, Inc. is a Torrance, California, private pharmaceutical company dedicated to developing and bringing to market new treatments for rare diseases and conditions. Emmaus Medical launched its first product, NutreStore [L-glutamine powder for oral solution] for the treatment of Short Bowel Syndrome (SBS) in June 2008. Emmaus Medical is currently conducting a Phase 3 clinical trial to investigate the safety and efficacy of oral L-glutamine for the treatment of sickle cell disease. Emmaus Medical has received FDA orphan drug designation and fast track designation for its sickle cell treatment.